Related Experiment Video
Updated: Jan 15, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
668
The Conundrum of Intermediate Risk in Localised Prostate Cancer: One Group, Many Realities
Arthur Peyrottes1, Guillaume Ploussard2, Paul Sargos3
1Urology Department, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France.
European Urology Oncology
|October 12, 2025
Abstract:
For intermediate-risk prostate cancer, definitions remain inconsistent and management varies. Greater precision is urgently needed via optimal use of existing tools and integration of emerging innovations to harmonise care and improve outcomes for this most common disease category.

